secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K/A
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001493152-24-007138
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio raises $8M via Series A Preferred, assumes >$4.2M liabilities via Series B Preferred
--------------------------------------------------------------------------------

- Series A Preferred raised $8M in two installments ($2M due Feb 15, $6M by Mar 16); convertible into 2M shares.
- Series A carries 5% cumulative dividend (increases 2% annually); callable if 20-day VWAP >$5.00 and S-1 effective.
- Series B Preferred issued to SSVK for assuming >$4.2M liabilities; 3.5% quarterly dividend (up to 7.5% quarterly cap).
- SSVK converted $1.5M and Mr. Ajjarapu converted $240K loans into common at $10/share; $2M merger obligation reduced to $500K.
- Issued 600K shares to two financial institutions for capital markets advisory services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224007138/0001493152-24-007138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224007138/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer